Programmed Death Ligand-1 Blocker [EPC]

Programmed Death Ligand-1 Blocker [EPC] was reported 21581 times

Drugs of the Programmed Death Ligand-1 Blocker [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 EPITHELITIS 16 0.7619
1 RADIATION PNEUMONITIS 814 0.3800
2 OESOPHAGOMEDIASTINAL FISTULA 7 0.3500
3 DIFFUSE UVEAL MELANOCYTIC PROLIFERATION 6 0.3158
4 BILE DUCT CANCER RECURRENT 7 0.2500
5 NON-SMALL CELL LUNG CANCER RECURRENT 64 0.2261
6 IMMUNOTOXICITY 22 0.1930
7 TUMOUR HYPERPROGRESSION 46 0.1855
8 PULMONARY RADIATION INJURY 11 0.1803
9 ARTERIAL INTRAMURAL HAEMATOMA 11 0.1375
10 ENDOCRINE TOXICITY 14 0.1373
11 RADIATION INTERACTION 11 0.1325
12 LIVER CARCINOMA RUPTURED 33 0.1310
13 IMMUNE-MEDIATED NEPHRITIS 58 0.1237
14 BILIARY TRACT INFECTION 75 0.1206
15 MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS OVERLAP SYNDROME 26 0.1140
16 SICCA SYNDROME 21 0.1088
17 PARANEOPLASTIC NEUROLOGICAL SYNDROME 13 0.1016
18 PROTEIN INDUCED BY VITAMIN K ABSENCE OR ANTAGONIST II INCREASED 7 0.0959
19 CHOLANGITIS INFECTIVE 24 0.0902
20 IMMUNE-MEDIATED PNEUMONITIS 20 0.0855
21 IMMUNE-MEDIATED HEPATIC DISORDER 151 0.0774
22 IMMUNE-MEDIATED MYOCARDITIS 121 0.0749
23 IMMUNE-MEDIATED HEPATITIS 149 0.0729
24 RADIATION OESOPHAGITIS 27 0.0709
25 IMMUNE-MEDIATED LUNG DISEASE 129 0.0707
26 ENDOMETRIAL CANCER RECURRENT 9 0.0687
27 TRANSITIONAL CELL CARCINOMA METASTATIC 8 0.0684
28 BACTERIAL ABDOMINAL INFECTION 10 0.0680
29 LUNG ADENOCARCINOMA RECURRENT 7 0.0680
30 THROMBOPHLEBITIS MIGRANS 23 0.0676
31 IMMUNE-MEDIATED DERMATITIS 68 0.0675
32 IMMUNE-MEDIATED CHOLANGITIS 24 0.0669
33 IMMUNE-MEDIATED ENTEROCOLITIS 246 0.0668
34 SILENT THYROIDITIS 9 0.0625
35 IMMUNE-MEDIATED MYASTHENIA GRAVIS 20 0.0615
36 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 76 0.0610
37 AUTOIMMUNE NEPHRITIS 12 0.0545
38 BRONCHIAL FISTULA 11 0.0545
39 AUTOIMMUNE LUNG DISEASE 6 0.0508
40 SUSPECTED DRUG-INDUCED LIVER INJURY 10 0.0500
41 IMMUNE-MEDIATED ARTHRITIS 19 0.0499
42 IMMUNE-MEDIATED ENCEPHALITIS 26 0.0491
43 KL-6 INCREASED 11 0.0487
44 IMMUNE-MEDIATED RENAL DISORDER 20 0.0483
45 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 42 0.0478
46 IMMUNE-MEDIATED PANCREATITIS 18 0.0472
47 METASTASES TO ADRENALS 43 0.0466
48 AUTOIMMUNE MYOCARDITIS 10 0.0457
49 IMMUNE-MEDIATED NEUROPATHY 7 0.0452
50 CHOLANGITIS 274 0.0442
51 IMMUNE-MEDIATED ADVERSE REACTION 66 0.0430
52 AUTOIMMUNE HYPOTHYROIDISM 10 0.0420
53 LYMPHOMA TRANSFORMATION 15 0.0417
54 IMMUNE-MEDIATED HYPOTHYROIDISM 46 0.0408
55 IMMUNE-MEDIATED THYROIDITIS 20 0.0405
56 MILLER FISHER SYNDROME 9 0.0402
57 HYPOPHYSITIS 79 0.0392
58 DYSBIOSIS 32 0.0390
59 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 31 0.0389
60 IMMUNE-MEDIATED HYPOPHYSITIS 17 0.0377
61 FULMINANT TYPE 1 DIABETES MELLITUS 38 0.0369
62 THYROIDITIS 106 0.0353
63 PNEUMONITIS 947 0.0347
64 TRANSFUSION-RELATED CIRCULATORY OVERLOAD 8 0.0331
65 ENTEROCOLITIS INFECTIOUS 30 0.0325
66 INFECTED NEOPLASM 8 0.0321
67 IMMUNE-MEDIATED HYPERTHYROIDISM 8 0.0315
68 CHOLANGIOCARCINOMA 45 0.0302
69 BILIARY OBSTRUCTION 39 0.0301
70 METASTASES TO CENTRAL NERVOUS SYSTEM 376 0.0291
71 LYMPHOCYTIC HYPOPHYSITIS 8 0.0290
72 EOSINOPHILIC FASCIITIS 10 0.0288
73 HYPERCREATININAEMIA 14 0.0278
74 CHOLANGITIS ACUTE 21 0.0278
75 MYOCARDITIS 317 0.0276
76 INTESTINAL METASTASIS 10 0.0275
77 IMMUNE-MEDIATED MYOSITIS 76 0.0275
78 SARCOID-LIKE REACTION 7 0.0271
79 BILE DUCT STENOSIS 32 0.0267
80 HYPOPITUITARISM 46 0.0264
81 ENCEPHALITIS AUTOIMMUNE 34 0.0259
82 TUMOUR PERFORATION 8 0.0252
83 ENDOCRINE DISORDER 32 0.0249
84 AUTOIMMUNE COLITIS 16 0.0248
85 NEPHRITIS 82 0.0245
86 ALPHA 1 FOETOPROTEIN INCREASED 17 0.0239
87 LICHENOID KERATOSIS 54 0.0236
88 PULMONARY NECROSIS 8 0.0235
89 DUODENAL OBSTRUCTION 7 0.0233
90 AUTOIMMUNE MYOSITIS 11 0.0233
91 SUPERIOR VENA CAVA SYNDROME 14 0.0232
92 TUMOUR RUPTURE 13 0.0231
93 TUMOUR PSEUDOPROGRESSION 25 0.0228
94 HEPATIC INFECTION 28 0.0219
95 MYOSITIS 193 0.0215
96 ADRENAL DISORDER 41 0.0213
97 GLUCOCORTICOID DEFICIENCY 9 0.0213
98 LIVER ABSCESS 69 0.0213
99 PULMONARY TOXICITY 147 0.0208
100 BLOOD CORTICOTROPHIN INCREASED 6 0.0208
101 OCULAR MYASTHENIA 7 0.0204
102 EVANS SYNDROME 10 0.0203
103 ADRENAL INSUFFICIENCY 244 0.0201
104 HYPOTHALAMO-PITUITARY DISORDER 28 0.0192
105 HYPERLIPASAEMIA 10 0.0191
106 METASTASES TO PLEURA 20 0.0191
107 BACILLUS INFECTION 12 0.0190
108 SMALL CELL LUNG CANCER 28 0.0185
109 BLOOD CORTICOTROPHIN DECREASED 9 0.0184
110 METASTASES TO PANCREAS 8 0.0181
111 AUTOIMMUNE PANCREATITIS 9 0.0178
112 MYASTHENIA GRAVIS 141 0.0174
113 MALIGNANT NEOPLASM PROGRESSION 1762 0.0172
114 IMMUNE THROMBOCYTOPENIA 77 0.0168
115 CORTISOL DECREASED 19 0.0166
116 DUODENAL STENOSIS 8 0.0165
117 LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT 10 0.0161
118 BRONCHOPLEURAL FISTULA 6 0.0160
119 ENTEROCOLITIS 92 0.0159
120 MALIGNANT TRANSFORMATION 7 0.0156
121 MYASTHENIC SYNDROME 12 0.0155
122 CYTOKINE STORM 10 0.0146
123 SKIN TOXICITY 82 0.0145
124 HAEMOBILIA 6 0.0145
125 CAUDA EQUINA SYNDROME 11 0.0143
126 MYOCARDIAL NECROSIS MARKER INCREASED 24 0.0143
127 GASTROINTESTINAL TOXICITY 68 0.0141
128 CHOLANGITIS SCLEROSING 28 0.0136
129 LYMPHANGIOSIS CARCINOMATOSA 14 0.0134
130 PARANEOPLASTIC SYNDROME 9 0.0133
131 CREATINE KINASE INCREASED 10 0.0130
132 ENCEPHALITIS 88 0.0127
133 CYTOKINE RELEASE SYNDROME 254 0.0126
134 HYPERTHYROIDISM 183 0.0126
135 TYPE 1 DIABETES MELLITUS 76 0.0126
136 BILE DUCT CANCER 15 0.0126
137 METASTASES TO SKIN 13 0.0126
138 LUNG OPACITY 33 0.0125
139 INFECTIOUS PLEURAL EFFUSION 19 0.0125
140 HYPOTHYROIDISM 398 0.0124
141 MALIGNANT PLEURAL EFFUSION 21 0.0124
142 INTERSTITIAL LUNG DISEASE 596 0.0123
143 NEUROENDOCRINE CARCINOMA OF THE SKIN 12 0.0123
144 COLITIS 451 0.0119
145 METASTASES TO PERITONEUM 30 0.0119
146 METASTASES TO LYMPH NODES 79 0.0117
147 CRITICAL ILLNESS 9 0.0115
148 HYPERSENSITIVITY PNEUMONITIS 13 0.0114
149 MYELITIS TRANSVERSE 16 0.0113
150 CARBOHYDRATE ANTIGEN 19-9 INCREASED 6 0.0113
151 HEPATOBILIARY DISEASE 7 0.0112
152 NON-SMALL CELL LUNG CANCER 53 0.0111
153 INTERLEUKIN LEVEL INCREASED 6 0.0109
154 CARCINOEMBRYONIC ANTIGEN INCREASED 21 0.0108
155 HAEMATOTOXICITY 103 0.0108
156 NEUTROPHIL COUNT DECREASED 441 0.0108
157 METASTASES TO MENINGES 24 0.0105
158 PULMONARY ARTERY THROMBOSIS 8 0.0104
159 PANCREATIC ENZYMES INCREASED 15 0.0102
160 MYELOSUPPRESSION 368 0.0102
161 AORTITIS 7 0.0102
162 NEUROENDOCRINE CARCINOMA 7 0.0101
163 ORGANISING PNEUMONIA 50 0.0101
164 POLYMYALGIA RHEUMATICA 32 0.0101
165 RHEUMATIC DISORDER 19 0.0098
166 METASTASIS 70 0.0098
167 SYSTEMIC SCLERODERMA 7 0.0096
168 GALLBLADDER CANCER 14 0.0095
169 APLASIA PURE RED CELL 32 0.0093
170 SECONDARY ADRENOCORTICAL INSUFFICIENCY 14 0.0093
171 DUODENAL PERFORATION 9 0.0092
172 MALIGNANT ASCITES 7 0.0091
173 TUMOUR HAEMORRHAGE 26 0.0091
174 CYTOMEGALOVIRUS ENTEROCOLITIS 7 0.0091
175 HILAR LYMPHADENOPATHY 8 0.0091
176 PEMPHIGOID 68 0.0090
177 METASTASES TO LIVER 158 0.0090
178 MYOCARDIAL INJURY 10 0.0089
179 HEPATITIS 226 0.0088
180 DERMATITIS PSORIASIFORM 18 0.0088
181 SIALOADENITIS 12 0.0088
182 OESOPHAGITIS 96 0.0088
183 DEMYELINATING POLYNEUROPATHY 9 0.0087
184 GUILLAIN-BARRE SYNDROME 42 0.0087
185 RADIATION SKIN INJURY 10 0.0086
186 LUNG ABSCESS 18 0.0086
187 METASTASES TO LUNG 99 0.0086
188 PHYSICAL DECONDITIONING 22 0.0085
189 TROPONIN INCREASED 65 0.0085
190 VITILIGO 20 0.0085
191 METASTASES TO BONE 139 0.0085
192 URINARY TRACT OBSTRUCTION 20 0.0084
193 PORTAL VEIN THROMBOSIS 27 0.0083
194 BRAIN STEM SYNDROME 6 0.0080
195 RENAL COLIC 18 0.0080
196 BILIARY TRACT DISORDER 11 0.0079
197 HYPERLEUKOCYTOSIS 7 0.0079
198 METASTATIC MALIGNANT MELANOMA 18 0.0078
199 MYELITIS 12 0.0077
200 METASTASES TO SPINE 26 0.0077
201 ADRENOCORTICAL INSUFFICIENCY ACUTE 15 0.0077
202 ENTERITIS 49 0.0076
203 JAUNDICE CHOLESTATIC 27 0.0076
204 BRONCHIAL CARCINOMA 6 0.0076
205 HEPATIC CYTOLYSIS 97 0.0076
206 AUTOIMMUNE HAEMOLYTIC ANAEMIA 26 0.0076
207 BILIARY DILATATION 11 0.0075
208 HEPATIC FUNCTION ABNORMAL 279 0.0075
209 SMALL INTESTINAL PERFORATION 14 0.0075
210 VASCULAR PSEUDOANEURYSM 13 0.0075
211 NEOPLASM PROGRESSION 249 0.0072
212 LUNG CONSOLIDATION 20 0.0071
213 HAEMOPHILUS INFECTION 7 0.0071
214 CANCER PAIN 18 0.0070
215 POLYNEUROPATHY 84 0.0070
216 ENDOCRINE OPHTHALMOPATHY 6 0.0069
217 ACQUIRED GENE MUTATION 9 0.0069
218 TUMOUR PAIN 9 0.0068
219 ACUTE PROMYELOCYTIC LEUKAEMIA 7 0.0068
220 PNEUMONIA BACTERIAL 62 0.0067
221 OXYGEN THERAPY 11 0.0067
222 TUMOUR NECROSIS 7 0.0066
223 AUTOIMMUNE HEPATITIS 46 0.0066
224 RADIATION INJURY 7 0.0066
225 NEUROMYOPATHY 7 0.0066
226 HEPATORENAL SYNDROME 11 0.0065
227 ADENOCARCINOMA GASTRIC 6 0.0065
228 CYTOPENIA 79 0.0064
229 POLYARTHRITIS 34 0.0064
230 DISEASE PROGRESSION 761 0.0064
231 TROPONIN T INCREASED 8 0.0063
232 POSTOPERATIVE WOUND COMPLICATION 8 0.0063
233 POLYMYOSITIS 11 0.0062
234 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 11 0.0062
235 PNEUMOTHORAX 97 0.0061
236 DEVICE RELATED THROMBOSIS 6 0.0061
237 PULMONARY TUBERCULOSIS 26 0.0061
238 EMBOLISM 50 0.0060
239 PERIPHERAL SENSORY NEUROPATHY 35 0.0060
240 OTOTOXICITY 11 0.0059
241 HENOCH-SCHONLEIN PURPURA 13 0.0059
242 LIVER DISORDER 259 0.0058
243 THYROID DISORDER 90 0.0058
244 CHOLESTATIC LIVER INJURY 13 0.0058
245 GRANULOMATOSIS WITH POLYANGIITIS 7 0.0058
246 CHRONIC RESPIRATORY FAILURE 7 0.0058
247 LYMPHADENOPATHY MEDIASTINAL 11 0.0057
248 VASCULAR PURPURA 8 0.0057
249 EXTREMITY NECROSIS 10 0.0057
250 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 8 0.0057
251 RADICULOPATHY 15 0.0057
252 FEBRILE NEUTROPENIA 377 0.0057
253 PRERENAL FAILURE 8 0.0057
254 IMMUNE THROMBOCYTOPENIC PURPURA 16 0.0057
255 FEBRILE BONE MARROW APLASIA 24 0.0056
256 TUMOUR MARKER INCREASED 27 0.0056
257 PNEUMONIA LEGIONELLA 9 0.0056
258 METASTATIC NEOPLASM 24 0.0056
259 RECURRENT CANCER 22 0.0054
260 CLOSTRIDIUM DIFFICILE COLITIS 57 0.0054
261 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 6 0.0053
262 DEATH 4536 0.0053
263 ARTERIAL HAEMORRHAGE 6 0.0052
264 DERMATOMYOSITIS 13 0.0051
265 BICYTOPENIA 10 0.0051
266 OPHTHALMOPLEGIA 8 0.0051
267 GASTROINTESTINAL PERFORATION 21 0.0050
268 CULTURE URINE POSITIVE 7 0.0050
269 MONOPARESIS 9 0.0050
270 KERATITIS 15 0.0049
271 CUTANEOUS VASCULITIS 18 0.0049
272 AMYLASE INCREASED 18 0.0049
273 HEPATIC ENCEPHALOPATHY 45 0.0048
274 STRESS CARDIOMYOPATHY 28 0.0048
275 AZOTAEMIA 19 0.0048
276 LICHEN PLANUS 11 0.0047
277 PERFORMANCE STATUS DECREASED 22 0.0047
278 HEPATIC MASS 9 0.0047
279 DRUG-INDUCED LIVER INJURY 146 0.0046
280 PROCTITIS 13 0.0046
281 CUTANEOUS LUPUS ERYTHEMATOSUS 9 0.0046
282 BLOOD THYROID STIMULATING HORMONE DECREASED 21 0.0046
283 RENAL TUBULAR DISORDER 13 0.0046
284 CELL DEATH 9 0.0045
285 MULTIPLE ORGAN DYSFUNCTION SYNDROME 128 0.0045
286 BLOOD CREATINE INCREASED 20 0.0045
287 HAEMATOLOGICAL INFECTION 11 0.0045
288 INTRA-ABDOMINAL FLUID COLLECTION 8 0.0045
289 NEOPLASM RECURRENCE 15 0.0044
290 PLEURAL EFFUSION 269 0.0044
291 CARDIAC TAMPONADE 21 0.0044
292 PLEURISY 26 0.0044
293 HEPATOCELLULAR CARCINOMA 33 0.0043
294 LUNG DISORDER 209 0.0043
295 ACUTE CORONARY SYNDROME 35 0.0042
296 HYPOPROTEINAEMIA 8 0.0042
297 CEREBRAL INFARCTION 103 0.0042
298 TUBULOINTERSTITIAL NEPHRITIS 79 0.0042
299 TUMOUR LYSIS SYNDROME 37 0.0042
300 HYPERPHOSPHATAEMIA 9 0.0042
301 ASCITES 122 0.0041
302 EXTRAVASATION 17 0.0041
303 INTESTINAL PERFORATION 46 0.0041
304 PNEUMOCYSTIS JIROVECII PNEUMONIA 41 0.0041
305 MULTI-ORGAN DISORDER 8 0.0041
306 THROMBOCYTOPENIA 454 0.0041
307 LIPASE INCREASED 31 0.0040
308 DERMATITIS EXFOLIATIVE GENERALISED 14 0.0040
309 EMPYEMA 8 0.0040
310 PULMONARY ALVEOLAR HAEMORRHAGE 22 0.0039
311 ABDOMINAL INFECTION 10 0.0039
312 ATRIOVENTRICULAR BLOCK COMPLETE 26 0.0039
313 VENOUS THROMBOSIS LIMB 8 0.0039
314 KETOACIDOSIS 29 0.0039
315 ERYTHEMA MULTIFORME 36 0.0039
316 DERMATITIS 80 0.0038
317 PLATELET COUNT DECREASED 406 0.0038
318 CHOLECYSTITIS 45 0.0038
319 FACIAL PARALYSIS 32 0.0038
320 EYELID PTOSIS 38 0.0037
321 TRANSAMINASES INCREASED 83 0.0037
322 THROMBOTIC THROMBOCYTOPENIC PURPURA 13 0.0037
323 OESOPHAGEAL VARICES HAEMORRHAGE 8 0.0037
324 RETROPERITONEAL HAEMORRHAGE 9 0.0036
325 APLASIA 7 0.0036
326 SUSPECTED OFF LABEL USE 16 0.0035
327 CEREBRAL THROMBOSIS 10 0.0035
328 OESOPHAGEAL STENOSIS 10 0.0035
329 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 36 0.0035
330 BLOOD THYROID STIMULATING HORMONE INCREASED 32 0.0035
331 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 26 0.0035
332 HAEMOLYTIC URAEMIC SYNDROME 8 0.0034
333 UPPER GASTROINTESTINAL HAEMORRHAGE 58 0.0034
334 NEPHROPATHY TOXIC 38 0.0034
335 CHOLESTASIS 65 0.0034
336 JAUNDICE 91 0.0034
337 INFUSION RELATED REACTION 224 0.0034
338 NEUTROPENIC SEPSIS 24 0.0034
339 LIVER FUNCTION TEST INCREASED 72 0.0034
340 SMALL INTESTINAL OBSTRUCTION 41 0.0033
341 MIXED LIVER INJURY 10 0.0033
342 PROTEINURIA 63 0.0033
343 GASTRIC PERFORATION 9 0.0033
344 LYMPHADENITIS 8 0.0033
345 HICCUPS 27 0.0033
346 CARDIOTOXICITY 29 0.0032
347 BLOOD DISORDER 26 0.0032
348 HEPATIC FAILURE 97 0.0032
349 HYPOALBUMINAEMIA 25 0.0032
350 NEPHROTIC SYNDROME 22 0.0032
351 DISSEMINATED INTRAVASCULAR COAGULATION 45 0.0032
352 OXYGEN SATURATION ABNORMAL 9 0.0032
353 SARCOIDOSIS 15 0.0032
354 BLOOD BILIRUBIN INCREASED 85 0.0031
355 DUODENAL ULCER HAEMORRHAGE 9 0.0031
356 BILE DUCT STONE 10 0.0031
357 ILEUS 39 0.0031
358 ADENOCARCINOMA 7 0.0031
359 THROMBOTIC MICROANGIOPATHY 30 0.0031
360 PERICARDIAL EFFUSION 71 0.0031
361 PULMONARY HAEMORRHAGE 24 0.0031
362 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 71 0.0030
363 BACTERAEMIA 36 0.0030
364 LOCALISED OEDEMA 14 0.0030
365 LARGE INTESTINE PERFORATION 21 0.0030
366 SUDDEN DEATH 32 0.0030
367 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 8 0.0030
368 CHOLECYSTITIS ACUTE 17 0.0030
369 DRUG ERUPTION 53 0.0030
370 POTENTIATING DRUG INTERACTION 10 0.0030
371 CARDIAC DYSFUNCTION 11 0.0030
372 SKIN DISORDER 98 0.0029
373 NEUROPATHY PERIPHERAL 278 0.0029
374 ORAL FUNGAL INFECTION 8 0.0029
375 HAEMOPTYSIS 81 0.0029
376 SEPTIC SHOCK 126 0.0029
377 APPENDICITIS 27 0.0029
378 THYROID FUNCTION TEST ABNORMAL 12 0.0029
379 ANAEMIA 550 0.0029
380 LEUKOPENIA 144 0.0029
381 HYPERTRANSAMINASAEMIA 20 0.0029
382 CARDIOMYOPATHY 42 0.0028
383 RESPIRATORY FAILURE 207 0.0028
384 NECROTISING FASCIITIS 10 0.0028
385 IMMUNE SYSTEM DISORDER 37 0.0028
386 PNEUMATOSIS INTESTINALIS 8 0.0028
387 HYPERBILIRUBINAEMIA 29 0.0028
388 LUNG CANCER METASTATIC 8 0.0028
389 KLEBSIELLA INFECTION 14 0.0028
390 NEUTROPENIA 374 0.0027
391 GASTROINTESTINAL NECROSIS 8 0.0027
392 ELECTROCARDIOGRAM T WAVE INVERSION 6 0.0027
393 COVID-19 PNEUMONIA 32 0.0027
394 DIABETIC KETOACIDOSIS 65 0.0027
395 THERAPY PARTIAL RESPONDER 42 0.0027
396 ASPARTATE AMINOTRANSFERASE INCREASED 143 0.0027
397 AGRANULOCYTOSIS 50 0.0027
398 APLASTIC ANAEMIA 14 0.0027
399 HYPOXIA 94 0.0027
400 MYOPATHY 23 0.0027
401 LUNG ADENOCARCINOMA 8 0.0027
402 BONE MARROW DISORDER 8 0.0026
403 GENERAL PHYSICAL HEALTH DETERIORATION 306 0.0026
404 DUODENITIS 8 0.0026
405 HEPATOTOXICITY 58 0.0026
406 SEPSIS 289 0.0026
407 OPTIC ISCHAEMIC NEUROPATHY 10 0.0026
408 BRONCHOPULMONARY ASPERGILLOSIS 20 0.0026
409 GAMMA-GLUTAMYLTRANSFERASE INCREASED 57 0.0026
410 BLOOD CREATINE PHOSPHOKINASE INCREASED 74 0.0026
411 ALANINE AMINOTRANSFERASE INCREASED 157 0.0026
412 PANCYTOPENIA 142 0.0025
413 HYPERGLYCAEMIA 92 0.0025
414 HYPOMAGNESAEMIA 35 0.0025
415 HUMERUS FRACTURE 12 0.0025
416 NEUTROPHIL COUNT ABNORMAL 7 0.0025
417 RASH MACULO-PAPULAR 55 0.0025
418 ILEUS PARALYTIC 11 0.0025
419 HEPATIC NEOPLASM 8 0.0024
420 MENINGITIS ASEPTIC 11 0.0024
421 PERIPHERAL ISCHAEMIA 10 0.0024
422 PYELONEPHRITIS 21 0.0024
423 HYDRONEPHROSIS 18 0.0024
424 DISEASE COMPLICATION 11 0.0024
425 CARDIAC FAILURE ACUTE 16 0.0024
426 PULMONARY PAIN 7 0.0024
427 MENINGITIS 16 0.0024
428 AUTOIMMUNE THYROIDITIS 9 0.0024
429 PERICARDITIS 40 0.0024
430 ATELECTASIS 23 0.0024
431 BRAIN OEDEMA 30 0.0024
432 HYPERPYREXIA 10 0.0024
433 HEPATITIS FULMINANT 7 0.0024
434 PYREXIA 814 0.0024
435 DERMATITIS BULLOUS 17 0.0023
436 HAEMOLYTIC ANAEMIA 21 0.0023
437 CEREBRAL ISCHAEMIA 12 0.0023
438 VARICES OESOPHAGEAL 7 0.0023
439 HEPATIC LESION 10 0.0023
440 ASPERGILLUS INFECTION 15 0.0023
441 LUNG INFILTRATION 20 0.0023
442 NEOPLASM 26 0.0023
443 COMPRESSION FRACTURE 12 0.0022
444 ACUTE RESPIRATORY FAILURE 43 0.0022
445 PANCREATIC DISORDER 11 0.0022
446 TASTE DISORDER 45 0.0022
447 PULMONARY MASS 33 0.0022
448 RENAL IMPAIRMENT 186 0.0022
449 SCLERODERMA 8 0.0022
450 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 21 0.0022
451 HYPONATRAEMIA 123 0.0022
452 MUCOSAL INFLAMMATION 57 0.0022
453 BRAIN NEOPLASM 20 0.0022
454 AORTIC DISSECTION 9 0.0022
455 UROSEPSIS 20 0.0022
456 AUTOIMMUNE DISORDER 21 0.0022
457 HEPATITIS ACUTE 14 0.0022
458 ACUTE PULMONARY OEDEMA 12 0.0021
459 CACHEXIA 11 0.0021
460 HEPATIC CIRRHOSIS 40 0.0021
461 PNEUMONIA ASPIRATION 53 0.0021
462 PANCREATITIS 111 0.0021
463 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 8 0.0021
464 ACUTE RESPIRATORY DISTRESS SYNDROME 37 0.0021
465 THYROID MASS 8 0.0021
466 DEVICE RELATED INFECTION 32 0.0021
467 ALTERED STATE OF CONSCIOUSNESS 45 0.0021
468 ATRIOVENTRICULAR BLOCK 16 0.0021
469 STEVENS-JOHNSON SYNDROME 46 0.0021
470 PRESYNCOPE 50 0.0021
471 FEEDING DISORDER 41 0.0020
472 DIABETES MELLITUS 154 0.0020
473 RENAL DISORDER 94 0.0020
474 IMMUNODEFICIENCY 30 0.0020
475 MYELODYSPLASTIC SYNDROME 29 0.0020
476 BLOOD CULTURE POSITIVE 6 0.0020
477 CREATININE RENAL CLEARANCE DECREASED 8 0.0020
478 INTESTINAL ISCHAEMIA 11 0.0020
479 ENCEPHALOPATHY 49 0.0020
480 HEPATITIS B 12 0.0020
481 GASTRIC ULCER HAEMORRHAGE 11 0.0020
482 EMBOLISM VENOUS 6 0.0020
483 ACUTE KIDNEY INJURY 301 0.0020
484 SKIN INFECTION 22 0.0020
485 CARDIAC FAILURE 157 0.0020
486 BRAIN NATRIURETIC PEPTIDE INCREASED 6 0.0019
487 SPONDYLITIS 7 0.0019
488 ACUTE MYELOID LEUKAEMIA 30 0.0019
489 GENERAL PHYSICAL CONDITION ABNORMAL 13 0.0019
490 PANCREATITIS ACUTE 43 0.0019
491 TOXIC EPIDERMAL NECROLYSIS 29 0.0019
492 EOSINOPHILIC PNEUMONIA 6 0.0019
493 COLITIS MICROSCOPIC 9 0.0019
494 VASCULITIS 22 0.0019
495 TOXIC SKIN ERUPTION 19 0.0019
496 HEPATIC PAIN 8 0.0019
497 LUNG NEOPLASM 8 0.0019
498 C-REACTIVE PROTEIN INCREASED 68 0.0019
499 UVEITIS 25 0.0018
500 SHOCK 42 0.0018
501 ABDOMINAL ABSCESS 8 0.0018
502 ELECTROLYTE IMBALANCE 21 0.0018
503 DECREASED APPETITE 418 0.0018
504 PNEUMONIA 582 0.0018
505 PNEUMONIA FUNGAL 7 0.0018
506 PULMONARY FIBROSIS 34 0.0018
507 BLOOD ALBUMIN DECREASED 14 0.0018
508 HYPOPHOSPHATAEMIA 13 0.0018
509 GRANULOCYTOPENIA 10 0.0018
510 CHILLS 205 0.0017
511 ARTERIOSPASM CORONARY 7 0.0017
512 ISCHAEMIA 8 0.0017
513 HYPERKALAEMIA 61 0.0017
514 BACTERIAL INFECTION 32 0.0017
515 OXYGEN SATURATION DECREASED 96 0.0017
516 HYPERURICAEMIA 7 0.0017
517 DUODENAL ULCER 12 0.0017
518 HYPERCALCAEMIA 21 0.0017
519 BONE MARROW FAILURE 34 0.0017
520 HYPOVOLAEMIC SHOCK 8 0.0017
521 WHITE BLOOD CELL COUNT DECREASED 181 0.0017
522 DIPLOPIA 43 0.0017
523 PULMONARY EMBOLISM 157 0.0017
524 DERMATITIS ACNEIFORM 10 0.0016
525 CARDIAC FAILURE CHRONIC 7 0.0016
526 HAEMATURIA 56 0.0016
527 PULMONARY OEDEMA 73 0.0016
528 ACUTE MYOCARDIAL INFARCTION 48 0.0016
529 LARYNGEAL OEDEMA 10 0.0016
530 INFLAMMATORY MARKER INCREASED 8 0.0016
531 MALNUTRITION 18 0.0016
532 INFUSION SITE EXTRAVASATION 10 0.0016
533 PROTEIN URINE PRESENT 8 0.0016
534 HEPATIC ENZYME ABNORMAL 8 0.0016
535 NEUROTOXICITY 28 0.0016
536 EMPHYSEMA 16 0.0016
537 ESCHERICHIA INFECTION 13 0.0016
538 ACIDOSIS 12 0.0016
539 DEVICE OCCLUSION 22 0.0016
540 SECOND PRIMARY MALIGNANCY 13 0.0016
541 HEPATOCELLULAR INJURY 22 0.0016
542 FAILURE TO THRIVE 8 0.0015
543 OPTIC NEURITIS 14 0.0015
544 CARDIOPULMONARY FAILURE 6 0.0015
545 GENERALISED OEDEMA 19 0.0015
546 LUNG NEOPLASM MALIGNANT 63 0.0015
547 INTESTINAL OBSTRUCTION 57 0.0015
548 HYPOKALAEMIA 69 0.0015
549 HEPATITIS CHOLESTATIC 9 0.0015
550 GASTRIC HAEMORRHAGE 17 0.0015
551 SHOCK HAEMORRHAGIC 12 0.0015
552 ANAPHYLACTIC SHOCK 38 0.0015
553 ASPHYXIA 12 0.0015
554 ATRIAL FIBRILLATION 143 0.0015
555 STOMATITIS 89 0.0015
556 GOITRE 6 0.0015
557 SUPRAVENTRICULAR TACHYCARDIA 14 0.0015
558 ASPIRATION 16 0.0015
559 BLOOD LACTATE DEHYDROGENASE INCREASED 23 0.0015
560 EOSINOPHIL COUNT INCREASED 12 0.0014
561 FEELING COLD 40 0.0014
562 LEUKOCYTOSIS 26 0.0014
563 HYPOCALCAEMIA 27 0.0014
564 GASTRIC ULCER 27 0.0014
565 HYPERVOLAEMIA 7 0.0014
566 EJECTION FRACTION DECREASED 22 0.0014
567 ASTHENIA 530 0.0014
568 DEEP VEIN THROMBOSIS 91 0.0014
569 LYMPHADENOPATHY 49 0.0014
570 BLOOD CREATININE INCREASED 90 0.0014
571 RALES 8 0.0014
572 TOXICITY TO VARIOUS AGENTS 232 0.0014
573 ARTHRITIS 108 0.0014
574 EOSINOPHILIA 24 0.0014
575 BLOOD ALKALINE PHOSPHATASE INCREASED 34 0.0014
576 HYPOPHAGIA 35 0.0014
577 HYPOVOLAEMIA 8 0.0014
578 ANKYLOSING SPONDYLITIS 18 0.0014
579 APPETITE DISORDER 9 0.0014
580 INFLAMMATION 70 0.0014
581 SKIN REACTION 19 0.0013
582 RESPIRATORY DISTRESS 37 0.0013
583 DIARRHOEA 863 0.0013
584 AORTIC ANEURYSM 10 0.0013
585 ECCHYMOSIS 9 0.0013
586 PERITONITIS 27 0.0013
587 GASTROENTERITIS 19 0.0013
588 ANAL ABSCESS 7 0.0013
589 HEMIPARESIS 22 0.0013
590 PIGMENTATION DISORDER 8 0.0013
591 GASTRITIS 34 0.0013
592 DEHYDRATION 172 0.0013
593 LYMPHOPENIA 18 0.0013
594 GASTROINTESTINAL PAIN 14 0.0013
595 RESPIRATORY TRACT INFECTION 33 0.0013
596 DEAFNESS 33 0.0013
597 RASH 548 0.0013
598 HEPATIC CANCER 30 0.0012
599 MUSCULAR WEAKNESS 141 0.0012
600 DELIRIUM 43 0.0012
601 DYSPHONIA 72 0.0012
602 HAEMOGLOBIN DECREASED 126 0.0012
603 LUNG INFECTION 19 0.0012
604 LIVER INJURY 30 0.0012
605 BLOOD SODIUM DECREASED 23 0.0012
606 LOWER GASTROINTESTINAL HAEMORRHAGE 9 0.0012
607 FRACTURE 23 0.0012
608 PHOTOSENSITIVITY REACTION 20 0.0012
609 DRUG RESISTANCE 31 0.0012
610 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 31 0.0012
611 INFECTION 171 0.0012
612 HAEMODYNAMIC INSTABILITY 9 0.0012
613 OEDEMA 64 0.0012
614 HYPERTHERMIA 9 0.0012
615 PSEUDOMONAS INFECTION 10 0.0012
616 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 60 0.0011
617 DYSPHAGIA 109 0.0011
618 ELECTROCARDIOGRAM ABNORMAL 9 0.0011
619 FULL BLOOD COUNT ABNORMAL 12 0.0011
620 ATRIAL FLUTTER 9 0.0011
621 GASTROINTESTINAL DISORDER 101 0.0011
622 BRONCHOSPASM 16 0.0011
623 SENSORY LOSS 9 0.0011
624 GAIT INABILITY 37 0.0011
625 RENAL FAILURE 147 0.0011
626 HAEMATEMESIS 28 0.0011
627 RESPIRATORY DISORDER 33 0.0011
628 ACUTE HEPATIC FAILURE 15 0.0011
629 CENTRAL NERVOUS SYSTEM LESION 15 0.0011
630 MOUTH HAEMORRHAGE 8 0.0011
631 CARDIAC ARREST 90 0.0011
632 SKIN ULCER 28 0.0011
633 APHONIA 15 0.0011
634 ANGIOPATHY 6 0.0011
635 THROMBOSIS 86 0.0011
636 DYSPNOEA 604 0.0011
637 HYPERTENSION 226 0.0011
638 DYSPNOEA EXERTIONAL 40 0.0011
639 REBOUND EFFECT 12 0.0011
640 MYOCARDIAL ISCHAEMIA 12 0.0011
641 CLOSTRIDIUM DIFFICILE INFECTION 23 0.0011
642 CARDIO-RESPIRATORY ARREST 44 0.0011
643 SPINAL FRACTURE 21 0.0010
644 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
645 BLOOD MAGNESIUM DECREASED 9 0.0010
646 PEMPHIGUS 13 0.0010
647 HAEMOLYSIS 8 0.0010
648 ARRHYTHMIA 49 0.0010
649 NEOPLASM MALIGNANT 69 0.0010
650 URINE OUTPUT DECREASED 9 0.0010
651 HAEMORRHAGIC STROKE 8 0.0010
652 LYMPHOCYTE COUNT DECREASED 18 0.0010
653 ISCHAEMIC STROKE 18 0.0010
654 ANAL INCONTINENCE 9 0.0010
655 RIGHT VENTRICULAR FAILURE 7 0.0010
656 MUSCLE DISORDER 8 0.0010
657 NEUTROPHIL COUNT INCREASED 10 0.0010
658 OFF LABEL USE 850 0.0010
659 SPINAL COMPRESSION FRACTURE 8 0.0010
660 NERVOUS SYSTEM DISORDER 30 0.0010
661 URINARY RETENTION 32 0.0010
662 HERPES ZOSTER 55 0.0010
663 ORAL DISORDER 7 0.0010
664 CEREBRAL HAEMORRHAGE 34 0.0009
665 CEREBRAL DISORDER 7 0.0009
666 HEPATIC ENZYME INCREASED 64 0.0009
667 HAEMOGLOBIN ABNORMAL 6 0.0009
668 SKIN HYPERPIGMENTATION 8 0.0009
669 HERPES SIMPLEX 6 0.0009
670 WRIST FRACTURE 11 0.0009
671 PULMONARY CONGESTION 12 0.0009
672 PARALYSIS 13 0.0009
673 CARDIOGENIC SHOCK 13 0.0009
674 MOVEMENT DISORDER 29 0.0009
675 CYTOMEGALOVIRUS INFECTION 15 0.0009
676 PRODUCTIVE COUGH 43 0.0009
677 COAGULOPATHY 15 0.0009
678 CEREBROVASCULAR ACCIDENT 152 0.0009
679 CANDIDA INFECTION 15 0.0009
680 ANAPHYLACTIC REACTION 49 0.0009
681 COUGH 248 0.0009
682 RENAL CYST 7 0.0009
683 ANGINA PECTORIS 25 0.0009
684 CONSTIPATION 190 0.0009
685 IRON DEFICIENCY ANAEMIA 8 0.0009
686 LIVER FUNCTION TEST ABNORMAL 25 0.0009
687 TRANSFUSION 9 0.0009
688 BLOOD PRESSURE DECREASED 57 0.0009
689 FLANK PAIN 8 0.0009
690 VENTRICULAR TACHYCARDIA 14 0.0008
691 ABDOMINAL PAIN 197 0.0008
692 METABOLIC ACIDOSIS 27 0.0008
693 RHABDOMYOLYSIS 35 0.0008
694 DRY MOUTH 68 0.0008
695 BEDRIDDEN 11 0.0008
696 MELAENA 18 0.0008
697 HYPOTENSION 164 0.0008
698 ANURIA 7 0.0008
699 VENTRICULAR FIBRILLATION 9 0.0008
700 COLON CANCER 12 0.0008
701 HAEMORRHAGE INTRACRANIAL 12 0.0008
702 VOMITING 377 0.0008
703 BLOOD CALCIUM DECREASED 9 0.0008
704 TACHYCARDIA 71 0.0008
705 PURPURA 7 0.0008
706 FATIGUE 615 0.0008
707 BODY TEMPERATURE INCREASED 16 0.0008
708 THIRST 14 0.0008
709 PRODUCT PRESCRIBING ISSUE 17 0.0008
710 NODULE 10 0.0008
711 NERVE COMPRESSION 7 0.0008
712 GASTROINTESTINAL HAEMORRHAGE 63 0.0008
713 ORTHOSTATIC HYPOTENSION 13 0.0007
714 HAEMORRHAGE 78 0.0007
715 SQUAMOUS CELL CARCINOMA 7 0.0007
716 URINARY INCONTINENCE 22 0.0007
717 PULMONARY THROMBOSIS 8 0.0007
718 URINARY TRACT INFECTION 124 0.0007
719 HEMIPLEGIA 6 0.0007
720 PULMONARY HYPERTENSION 15 0.0007
721 OBSTRUCTIVE AIRWAYS DISORDER 8 0.0007
722 SECRETION DISCHARGE 9 0.0007
723 MALAISE 313 0.0007
724 RENAL TUBULAR NECROSIS 7 0.0007
725 HEPATOMEGALY 7 0.0007
726 MOUTH ULCERATION 15 0.0007
727 CYANOSIS 11 0.0007
728 BLOOD POTASSIUM DECREASED 21 0.0007
729 FULL BLOOD COUNT DECREASED 14 0.0007
730 PANCREATIC CARCINOMA 20 0.0007
731 MYOCARDIAL INFARCTION 120 0.0007
732 EPILEPSY 21 0.0007
733 DYSSTASIA 20 0.0007
734 ORAL CANDIDIASIS 9 0.0007
735 SPLENOMEGALY 8 0.0007
736 RASH PRURITIC 37 0.0007
737 MYALGIA 116 0.0007
738 OEDEMA PERIPHERAL 83 0.0007
739 IMMUNOSUPPRESSION 6 0.0007
740 ADVERSE REACTION 9 0.0007
741 COVID-19 119 0.0007
742 BLOOD POTASSIUM INCREASED 11 0.0007
743 WEIGHT DECREASED 189 0.0007
744 COMA 32 0.0007
745 UPPER RESPIRATORY TRACT INFECTION 31 0.0007
746 INCONTINENCE 7 0.0007
747 IMPAIRED GASTRIC EMPTYING 9 0.0007
748 SYNCOPE 66 0.0007
749 GINGIVAL BLEEDING 9 0.0007
750 CONJUNCTIVITIS 12 0.0006
751 PRURITUS 248 0.0006
752 MASS 9 0.0006
753 RED BLOOD CELL COUNT DECREASED 18 0.0006
754 ULCER 10 0.0006
755 COLITIS ULCERATIVE 28 0.0006
756 RHEUMATOID ARTHRITIS 71 0.0006
757 CONFUSIONAL STATE 101 0.0006
758 BACK PAIN 145 0.0006
759 WHEEZING 37 0.0006
760 DRUG INTOLERANCE 60 0.0006
761 CARDIAC DISORDER 58 0.0006
762 LOWER RESPIRATORY TRACT INFECTION 28 0.0006
763 INTERNAL HAEMORRHAGE 7 0.0006
764 ECZEMA 32 0.0006
765 HOSPICE CARE 6 0.0006
766 SARS-COV-2 TEST POSITIVE 8 0.0006
767 NAUSEA 476 0.0006
768 QUALITY OF LIFE DECREASED 8 0.0006
769 HYPERSOMNIA 17 0.0006
770 MUSCULOSKELETAL CHEST PAIN 9 0.0006
771 RESPIRATORY ARREST 16 0.0006
772 MENTAL STATUS CHANGES 16 0.0006
773 LABORATORY TEST ABNORMAL 17 0.0006
774 STAPHYLOCOCCAL INFECTION 19 0.0006
775 CELLULITIS 29 0.0006
776 OESOPHAGEAL CARCINOMA 17 0.0006
777 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
778 BLOOD TEST ABNORMAL 8 0.0006
779 APHASIA 17 0.0006
780 CONDITION AGGRAVATED 170 0.0006
781 CHEST PAIN 103 0.0006
782 CARDIOVASCULAR DISORDER 14 0.0006
783 HYPOKINESIA 8 0.0006
784 RASH ERYTHEMATOUS 26 0.0005
785 HAEMATOCHEZIA 30 0.0005
786 HIATUS HERNIA 7 0.0005
787 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
788 SEIZURE 62 0.0005
789 HYPOGLYCAEMIA 26 0.0005
790 ALOPECIA 105 0.0005
791 NEURALGIA 13 0.0005
792 BLISTER 30 0.0005
793 CIRCULATORY COLLAPSE 9 0.0005
794 BRADYCARDIA 28 0.0005
795 LOWER LIMB FRACTURE 10 0.0005
796 LYMPHOMA 8 0.0005
797 TENDONITIS 8 0.0005
798 LOSS OF CONSCIOUSNESS 66 0.0005
799 TACHYPNOEA 7 0.0005
800 KIDNEY INFECTION 10 0.0005
801 FAECES DISCOLOURED 11 0.0005
802 ATAXIA 6 0.0005
803 DIVERTICULITIS 14 0.0005
804 TYPE 2 DIABETES MELLITUS 17 0.0005
805 DISEASE RECURRENCE 24 0.0005
806 MOBILITY DECREASED 36 0.0005
807 HEPATITIS C 6 0.0005
808 WHITE BLOOD CELL COUNT INCREASED 19 0.0005
809 BLOOD PRESSURE INCREASED 75 0.0005
810 SUBDURAL HAEMATOMA 7 0.0005
811 BLOOD GLUCOSE ABNORMAL 9 0.0005
812 EYE DISORDER 16 0.0005
813 INJECTION SITE EXTRAVASATION 6 0.0005
814 HEPATIC STEATOSIS 9 0.0005
815 AGEUSIA 12 0.0005
816 BLOOD UREA INCREASED 8 0.0005
817 SPEECH DISORDER 25 0.0005
818 DERMATITIS ALLERGIC 6 0.0005
819 SKIN LESION 13 0.0005
820 MUSCULOSKELETAL DISORDER 9 0.0005
821 FLUID RETENTION 24 0.0005
822 RENAL INJURY 14 0.0005
823 TREMOR 78 0.0005
824 EATING DISORDER 10 0.0005
825 PERIPHERAL SWELLING 72 0.0005
826 ARTHRALGIA 194 0.0005
827 HIP FRACTURE 15 0.0005
828 VERTIGO 28 0.0005
829 DISCOMFORT 28 0.0005
830 VIRAL INFECTION 15 0.0005
831 ABDOMINAL DISTENSION 47 0.0004
832 ORAL PAIN 10 0.0004
833 PSORIASIS 58 0.0004
834 HYPOAESTHESIA 66 0.0004
835 SCIATICA 7 0.0004
836 CORONARY ARTERY OCCLUSION 6 0.0004
837 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 24 0.0004
838 PRODUCT USE IN UNAPPROVED INDICATION 107 0.0004
839 DISORIENTATION 17 0.0004
840 BONE PAIN 25 0.0004
841 DYSARTHRIA 16 0.0004
842 ADVERSE EVENT 39 0.0004
843 HYPOACUSIS 18 0.0004
844 BLINDNESS 17 0.0004
845 POST PROCEDURAL COMPLICATION 8 0.0004
846 GLAUCOMA 8 0.0004
847 HYPERSENSITIVITY 76 0.0004
848 THERAPY CESSATION 21 0.0004
849 CYSTITIS 13 0.0004
850 ILLNESS 42 0.0004
851 BRONCHITIS 30 0.0004
852 BLOOD PRESSURE ABNORMAL 8 0.0004
853 LACTIC ACIDOSIS 13 0.0004
854 THERAPY NON-RESPONDER 18 0.0004
855 LETHARGY 23 0.0004
856 HEART RATE IRREGULAR 9 0.0004
857 GLYCOSYLATED HAEMOGLOBIN INCREASED 10 0.0004
858 GASTRIC CANCER 10 0.0004
859 NECK PAIN 22 0.0004
860 INSURANCE ISSUE 6 0.0004
861 GAIT DISTURBANCE 75 0.0004
862 CHEST DISCOMFORT 40 0.0004
863 GOUT 7 0.0004
864 FUNGAL INFECTION 13 0.0004
865 OSTEOMYELITIS 7 0.0004
866 TRANSIENT ISCHAEMIC ATTACK 13 0.0004
867 BASAL CELL CARCINOMA 6 0.0004
868 DYSURIA 14 0.0004
869 DEPRESSED LEVEL OF CONSCIOUSNESS 15 0.0004
870 ABSCESS 6 0.0004
871 THROAT TIGHTNESS 10 0.0004
872 FALL 122 0.0004
873 CORONARY ARTERY DISEASE 11 0.0004
874 HERNIA 7 0.0004
875 FACE OEDEMA 6 0.0004
876 RECTAL HAEMORRHAGE 15 0.0003
877 TINNITUS 16 0.0003
878 EPISTAXIS 26 0.0003
879 COGNITIVE DISORDER 16 0.0003
880 HEART RATE DECREASED 12 0.0003
881 DIZZINESS 169 0.0003
882 CATARACT 20 0.0003
883 CHOLELITHIASIS 11 0.0003
884 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 16 0.0003
885 PALLOR 9 0.0003
886 DYSPEPSIA 32 0.0003
887 PROCEDURAL PAIN 9 0.0003
888 EYE SWELLING 12 0.0003
889 PRODUCT DOSE OMISSION 21 0.0003
890 WEIGHT INCREASED 72 0.0003
891 PSORIATIC ARTHROPATHY 13 0.0003
892 NO ADVERSE EVENT 58 0.0003
893 PARAESTHESIA 50 0.0003
894 ABDOMINAL PAIN LOWER 8 0.0003
895 ABDOMINAL PAIN UPPER 65 0.0003
896 CARDIAC FAILURE CONGESTIVE 25 0.0003
897 UNRESPONSIVE TO STIMULI 8 0.0003
898 HAEMATOMA 8 0.0003
899 EAR PAIN 6 0.0003
900 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 9 0.0003
901 OSTEOARTHRITIS 13 0.0003
902 HEART RATE INCREASED 30 0.0003
903 CHRONIC KIDNEY DISEASE 23 0.0003
904 HAEMATOCRIT DECREASED 6 0.0003
905 RESTLESSNESS 11 0.0003
906 MENTAL DISORDER 13 0.0003
907 PAIN 183 0.0003
908 VISUAL IMPAIRMENT 36 0.0003
909 MUSCULOSKELETAL PAIN 15 0.0003
910 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 51 0.0003
911 ERYTHEMA 58 0.0003
912 ILL-DEFINED DISORDER 17 0.0003
913 NIGHT SWEATS 9 0.0003
914 ADVERSE DRUG REACTION 25 0.0003
915 SWELLING FACE 18 0.0003
916 FLUSHING 28 0.0003
917 MEDICATION ERROR 15 0.0003
918 OSTEOPOROSIS 11 0.0003
919 SWELLING 25 0.0003
920 CHROMATURIA 6 0.0003
921 DRUG INEFFECTIVE 348 0.0003
922 HYPERHIDROSIS 34 0.0003
923 URTICARIA 44 0.0003
924 SOMNOLENCE 52 0.0003
925 RASH MACULAR 9 0.0003
926 DYSGEUSIA 19 0.0003
927 INFLUENZA LIKE ILLNESS 21 0.0003
928 INTENTIONAL PRODUCT USE ISSUE 22 0.0003
929 GASTROOESOPHAGEAL REFLUX DISEASE 20 0.0002
930 AMNESIA 16 0.0002
931 THERAPY INTERRUPTED 17 0.0002
932 OROPHARYNGEAL PAIN 22 0.0002
933 SKIN EXFOLIATION 20 0.0002
934 ARTHROPATHY 13 0.0002
935 VISION BLURRED 32 0.0002
936 PAIN IN EXTREMITY 68 0.0002
937 PALPITATIONS 27 0.0002
938 INSOMNIA 61 0.0002
939 SLEEP DISORDER 16 0.0002
940 INFLUENZA 25 0.0002
941 HEAD INJURY 7 0.0002
942 BALANCE DISORDER 19 0.0002
943 SKIN DISCOLOURATION 10 0.0002
944 POLLAKIURIA 9 0.0002
945 DEMENTIA 6 0.0002
946 BLOOD GLUCOSE INCREASED 40 0.0002
947 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
948 MUSCULOSKELETAL STIFFNESS 18 0.0002
949 DISTURBANCE IN ATTENTION 11 0.0002
950 ANGIOEDEMA 9 0.0002
951 HEADACHE 127 0.0002
952 NASOPHARYNGITIS 37 0.0002
953 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
954 MEMORY IMPAIRMENT 27 0.0002
955 FEELING ABNORMAL 47 0.0002
956 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
957 FEMUR FRACTURE 6 0.0002
958 DEPRESSED MOOD 10 0.0002
959 ANXIETY 53 0.0002
960 UNEVALUABLE EVENT 14 0.0002
961 IMPAIRED HEALING 6 0.0002
962 DRY EYE 9 0.0002
963 MUSCLE SPASMS 33 0.0002
964 DRY SKIN 24 0.0002
965 FEELING HOT 11 0.0002
966 PRODUCT DOSE OMISSION ISSUE 52 0.0002
967 ABNORMAL BEHAVIOUR 7 0.0002
968 DEPRESSION 40 0.0002
969 PRODUCT USE ISSUE 33 0.0002
970 BLADDER CANCER 10 0.0002
971 HOSPITALISATION 26 0.0002
972 ASTHMA 19 0.0002
973 FLATULENCE 9 0.0002
974 JOINT SWELLING 19 0.0002
975 SINUSITIS 16 0.0002
976 THROAT IRRITATION 7 0.0002
977 IRRITABILITY 9 0.0001
978 ABDOMINAL DISCOMFORT 25 0.0001
979 HALLUCINATION 11 0.0001
980 HOT FLUSH 11 0.0001
981 BLOOD GLUCOSE DECREASED 7 0.0001
982 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
983 RHINORRHOEA 8 0.0001
984 SURGERY 7 0.0001
985 UNDERDOSE 8 0.0001
986 DRUG INTERACTION 16 0.0001
987 PROSTATE CANCER 8 0.0001
988 SKIN BURNING SENSATION 7 0.0001
989 TREATMENT FAILURE 7 0.0001
990 CONTUSION 8 0.0001
991 AGITATION 6 0.0001
992 OVERDOSE 11 0.0001
993 EMOTIONAL DISTRESS 6 0.0000
994 INCORRECT DOSE ADMINISTERED 7 0.0000